CBD Supplement Market Enforcement Based On FDA Concerns, Not Discretion

Although agency is prioritizing enforcement on hemp and CBD supplement and food products marketed with violative claims and allowing sales of products compliant with its regulations, the approach is not enforcement discretion, officials say. It's aware some companies are marketing hemp and CBD products "in ways that violate the law," and its "biggest concern" is products "that put the health and safety of consumers at greatest risk."

FDA entrance sign 2016

More from Regulation

More from Policy & Regulation